Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...
The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades. UTIs are infections in any part of the urinary system and affect ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...
Respiratory and sinus infections, along with strep throat, are some of the most common reasons for antibiotic use worldwide in the treatment of urinary tract infections (UTIs). UTIs are caused by ...
During the COVID pandemic, Jennifer Meddings, MD, noticed that many of her in-person patients presented with cases of Clostridioides difficile infections just a week or so after receiving antibiotics ...
Cranberry juice potentiates fosfomycin against UPEC, lowering resistance rates and modifying bacterial absorption pathways for improved antibiotic efficacy.
A new international study has uncovered a concerning lack of public understanding about cystitis and urinary tract infections (UTIs)—common health issues that disproportionately affect women. The ...
You wake up with that familiar urgency to go to the toilet and burning when you pee – and no matter how many times you go, that urgency doesn’t let up. You know exactly what it is: a urinary tract ...
Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results